Skip to content

Clinical trials

Terminated Observational Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Observational Status: Terminated Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20121
20161
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University2
Addario Lung Cancer Medical Institute1
Fate Therapeutics1
Fujirebio Diagnostics, Inc.1
HKGepitherapeutics1
Pathway Genomics1
Pierian Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma8
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms5
Carcinoma, Hepatocellular2
Colorectal Neoplasms2
Head and Neck Neoplasms2
Pancreatic Neoplasms2
Adenocarcinoma of Lung1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.